Your browser doesn't support javascript.
loading
Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making.
Németh, Bertalan; Kamusheva, Maria; Mitkova, Zornitsa; Petykó, Zsuzsanna Ida; Zemplényi, Antal; Dimitrova, Maria; Tachkov, Konstantin; Balkányi, László; Czech, Marcin; Dawoud, Dalia; Goettsch, Wim; Hren, Rok; Knies, Saskia; Lorenzovici, László; Maravic, Zorana; Piniazhko, Oresta; Zerovnik, Spela; Kaló, Zoltán.
Afiliação
  • Németh B; Syreon Research Institute, Budapest, HU 1142, Hungary.
  • Kamusheva M; Department of Organization & Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BG 1000, Bulgaria.
  • Mitkova Z; Department of Organization & Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BG 1000, Bulgaria.
  • Petykó ZI; Syreon Research Institute, Budapest, HU 1142, Hungary.
  • Zemplényi A; Syreon Research Institute, Budapest, HU 1142, Hungary.
  • Dimitrova M; Center for Health Technology Assessment & Pharmacoeconomics Research, Faculty of Pharmacy, University of Pécs, Pécs, Hungary.
  • Tachkov K; Department of Organization & Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BG 1000, Bulgaria.
  • Balkányi L; Department of Organization & Economics of Pharmacy, Faculty of Pharmacy, Medical University of Sofia, Sofia, BG 1000, Bulgaria.
  • Czech M; Medical Informatics R&D Center, Pannon University, Veszprém, HU 8200, Hungary.
  • Dawoud D; Department of Pharmacoeconomics, Institute of Mother & Child, Warsaw, PL 01-211, Poland.
  • Goettsch W; Science Policy & Research Programme, Science Evidence & Analytics Directorate, National Institute for Health & Care Excellence (NICE), London, United Kingdom.
  • Hren R; Cairo University, Faculty of Pharmacy, Cairo, Egypt.
  • Knies S; Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.
  • Lorenzovici L; National Health Care Institute, Diemen, NL 1120 AH, The Netherlands.
  • Maravic Z; Faculty of Mathematics & Physics, University of Ljubljana, Ljubljana, Slovenia.
  • Piniazhko O; National Health Care Institute, Diemen, NL 1120 AH, The Netherlands.
  • Zerovnik S; Syreon Research Romania, Tirgu Mures, RO 540004, Romania.
  • Kaló Z; G. E. Palade University of Medicine, Pharmacy, Science & Technology, Tirgu Mures, RO 540142, Romania.
J Comp Eff Res ; 12(4): e220157, 2023 04.
Article em En | MEDLINE | ID: mdl-36861458
ABSTRACT

Aim:

Real-world data and real-world evidence (RWE) are becoming more important for healthcare decision making and health technology assessment. We aimed to propose solutions to overcome barriers preventing Central and Eastern European (CEE) countries from using RWE generated in Western Europe. Materials &

methods:

To achieve this, following a scoping review and a webinar, the most important barriers were selected through a survey. A workshop was held with CEE experts to discuss proposed solutions.

Results:

Based on survey results, we selected the nine most important barriers. Multiple solutions were proposed, for example, the need for a European consensus, and building trust in using RWE.

Conclusion:

Through collaboration with regional stakeholders, we proposed a list of solutions to overcome barriers on transferring RWE from Western Europe to CEE countries.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica / Política de Saúde Tipo de estudo: Guideline / Health_technology_assessment Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica / Política de Saúde Tipo de estudo: Guideline / Health_technology_assessment Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article